Presentation TCT 2016 TCT 412: Long-term Clinical Outcomes of Transient and Persistent No-Reflow Following Percutaneous Coronary Intervention (PCI): Insights from a Multi-center Australian Registry Presenter: Mauricio G. Cohen, Bernhard Witzenbichler November 01, 2016
Presentation TCT 2016 Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic AF Patient Who Requires PCI Presenter: David P. Faxon, C. Michael Gibson, Deepak L. Bhatt November 01, 2016
Presentation TCT 2016 When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy? Presenter: David P. Faxon, C. Michael Gibson, Roxana Mehran November 01, 2016
Presentation TCT 2016 Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding Presenter: David P. Faxon, C. Michael Gibson November 01, 2016
Presentation TCT 2016 General Overview and Highlights of the North American Consensus Document on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI Presenter: David P. Faxon, C. Michael Gibson, Dominick J. Angiolillo November 01, 2016
Presentation TCT 2016 European Guidelines on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI Presenter: David P. Faxon, C. Michael Gibson, Davide Capodanno November 01, 2016
Presentation TCT 2016 What Is Known (and What Is Not) About Discontinuing Aspirin or Clopidogrel in Patients on Chronic Oral Anticoagulants Plus DAPT Presenter: David P. Faxon, C. Michael Gibson, Freek W.A. Verheugt November 01, 2016
Presentation TCT 2016 The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus DAPT Presenter: David P. Faxon, C. Michael Gibson, Christopher B. Granger November 01, 2016
Presentation TCT 2016 Opening Salvo: Despite EXCEL And NOBLE, I Don't Believe PCI Should Be the Standard Revascularization Strategy for Most Patients With Left Main CAD! Presenter: Sanjay Kaul, Jeffrey J. Popma, John D. Puskas November 01, 2016
Presentation TCT 2016 Return Fire: The Contrarian View - Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI! Presenter: Sanjay Kaul, Jeffrey J. Popma, Michael Haude November 01, 2016
Presentation TCT 2016 The Case for Multivessel PCI Presenter: John A. Bittl, David J. Maron, Sripal Bangalore November 01, 2016
News Conference News TCT 2016 ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events Michael O'Riordan November 01, 2016
Presentation TCT 2016 Opening Salvo: I Don't Believe Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI! Presenter: Sanjay Kaul, Jeffrey J. Popma, Salvatore Cassese November 01, 2016
Presentation TCT 2016 2016 CTO Revascularization Update Presenter: Sripal Bangalore, George D. Dangas, Khaldoon Alaswad November 01, 2016
Presentation TCT 2016 Opening Salvo: I Don't Believe That Door-to-Balloon Time Is a Critical Metric for Primary PCI In 2016! Presenter: David J. Cohen, Ajay J. Kirtane, Alan C. Yeung, Hitinder S. Gurm November 01, 2016
Presentation TCT 2016 Hot Topic #3: Anti-ischemic Therapy: Beta Blockers, ACE Inhibitors, and Ranolazine - Are They Effective? Presenter: Bernard J. Gersh, Felix Mahfoud, Ori Ben-Yehuda November 01, 2016
Presentation TCT 2016 2016 STEMI PCI Update: Evidence and Guidelines Presenter: Sripal Bangalore, George D. Dangas, Sanjit S. Jolly November 01, 2016
Presentation TCT 2016 2016 DAPT Update: Evidence and Guidelines Presenter: Sripal Bangalore, George D. Dangas, Adnan K. Chhatriwalla November 01, 2016
Presentation TCT 2016 Hot Topic #2: Lipid Lowering Targets and the Potential Role of the PSCK9 Inhibitors in Routine Clinical Practice Presenter: Bernard J. Gersh, Felix Mahfoud, Evan A. Stein November 01, 2016
Presentation TCT 2016 Lesion Optimization Before PCI: Role of Imaging/Atherectomy Presenter: Sripal Bangalore, George D. Dangas, Philippe Généreux November 01, 2016